The Shining sequel Doctor Sleep had a weak premiere and may lose 20 million

According to DeadLine's sources, Warner Bros. is very uneasy about "Doctor Sleep," an adaptation of Stephen King's novel that was released last week. After all additional revenues were counted, the global box office of the film reached 100 million, and it is estimated that the film will still lose 20 million US dollars.

"The direct sequel to the horror masterpiece "The Shining"", such a title still cannot support the appeal of horror movies to audiences today. "Doctor Sleep" box office was 14.1 million US dollars in its first weekend, far below the expected 25 million. The performance of the first weekend can often reflect how the film will perform in the cinema, and this is even more true for horror movies - usually the climax of the movie is concentrated in the first few days (unless it successfully creates a cultural phenomenon). Therefore, analysts have basically concluded that "Doctor Sleep" is unlikely to recover its budget in the domestic US market.

Warner Bros. executives may be surprised by the performance of Doctor Sleep, as the film's reviews tend to be good. IGN gave it an 8.5 when the media analyzed it, and the freshness on the Rotten Tomatoes website is currently stable at around 75%. As a sequel to The Shining, it did not destroy the brand.

Of course, a loss of 20 million is nothing for Warner in this quarter. The two "Joker cards" played by Warner this quarter - DC's "Joker" and "IT: Chapter 2" were very successful. The former's international revenue is expected to exceed 1 billion, and the latter's global box office has reached 460 million US dollars.